Loading…
Reported covered position: Legislative Fellow, Rep. Jan Schakowsky.
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: TRAVERE THERAPEUTICS · Firm: ALSTON & BIRD LLP
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding the Orphan Drug Act and rare disease diagnosis, treatment, and care. Legislation regarding kidney disease and in particular rare kidney disease. Legislation regarding newborn screening. H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Policies regarding copay accumulators and impact on rare disease patients. Support of reauthorization of priority review voucher program. H.R.1, One Big Beautiful Bill Act, provisions regarding orphan drugs.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: TRAVERE THERAPEUTICS · Firm: ALSTON & BIRD LLP
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
AMERICAN MEDICAL REHABILITATION PROVIDERS ASSOCIATION via ALSTON & BIRD LLP
2026 · first_quarter · Q1
Medicare reimbursement issues.
Medicare reimbursement issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KERECIS via
Source: Senate LDA
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation impacting products approved under the Accelerated Approval pathway. H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Policies regarding copay accumulators and impact on rare disease patients. H.R.1, One Big Beautiful Bill Act, provisions regarding orphan drugs.
New Era of Preventing End-Stage Kidney Disease Act
Client: TRAVERE THERAPEUTICS · Firm: ALSTON & BIRD LLP
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation impacting products approved under the Accelerated Approval pathway. H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Policies regarding copay accumulators and impact on rare disease patients. H.R.1, One Big Beautiful Bill Act, provisions regarding orphan drugs.
New Era of Preventing End-Stage Kidney Disease Act
Client: TRAVERE THERAPEUTICS · Firm: ALSTON & BIRD LLP
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding the Orphan Drug Act and rare disease diagnosis, treatment, and care. Legislation regarding kidney disease and in particular rare kidney disease. Legislation regarding newborn screening. H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Support of reauthorization of priority review voucher program. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding orphan drugs.
New Era of Preventing End-Stage Kidney Disease Act
Client: TRAVERE THERAPEUTICS · Firm: ALSTON & BIRD LLP
H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding orphan drugs, Medicare and Medicaid.
New Era of Preventing End-Stage Kidney Disease Act
Client: TRAVERE THERAPEUTICS · Firm: ALSTON & BIRD LLP
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding the Orphan Drug Act and rare disease diagnosis, treatment, and care. Legislation regarding kidney disease and in particular rare kidney disease. Legislation regarding newborn screening. H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Policies regarding copay accumulators and impact on rare disease patients. Support of reauthorization of priority review voucher program. H.R.1, One Big Beautiful Bill Act, provisions regarding orphan drugs.
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding the Orphan Drug Act and rare disease diagnosis, treatment, and care. Legislation regarding kidney disease and in particular rare kidney disease. Legislation regarding newborn screening. H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Policies regarding copay accumulators and impact on rare disease patients. Support of reauthorization of priority review voucher program. H.R.1, One Big Beautiful Bill Act, provisions regarding orphan drugs.
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding the Orphan Drug Act and rare disease diagnosis, treatment, and care. Legislation regarding kidney disease and in particular rare kidney disease. Legislation regarding newborn screening. H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Support of reauthorization of priority review voucher program. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding orphan drugs.
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation impacting products approved under the Accelerated Approval pathway. H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Policies regarding copay accumulators and impact on rare disease patients. H.R.1, One Big Beautiful Bill Act, provisions regarding orphan drugs.
Give Kids a Chance Act of 2024
Client: ST. JUDE CHILDREN'S RESEARCH HOSPITAL · Firm: ALSTON & BIRD LLP
Issues related to Medicaid; Public Readiness and Emergency Preparedness Act (PREP). H.R.3433/S.2897, Give Kids a Chance Act.
Give Kids a Chance Act of 2023
Client: ST. JUDE CHILDREN'S RESEARCH HOSPITAL · Firm: ALSTON & BIRD LLP
Issues related to Medicaid; Public Readiness and Emergency Preparedness Act (PREP). H.R.3433/S.2897, Give Kids a Chance Act.
2026 · first_quarter · Q1
General health care issues related to Medicare coverage policies. FY2027 Appropriations Bill.
General health care issues related to Medicare coverage policies. FY2027 Appropriations Bill.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · fourth_quarter · Q4
General health care issues related to Medicare coverage policies.
General health care issues related to Medicare coverage policies.
TRAVERE THERAPEUTICS via ALSTON & BIRD LLP
2025 · third_quarter · Q3
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding the Orphan Drug Act and rare disease diagnosis, treatment, and care. Legislation regarding kidney disease and in particular rare kidney disease. Legislation regarding newborn screening. H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Support of reauthorization of priority review voucher program. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding orphan drugs.
H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding orphan drugs, Medicare and Medicaid.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · third_quarter · Q3
General health care issues related to Medicare coverage policies.
General health care issues related to Medicare coverage policies.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
TRAVERE THERAPEUTICS via ALSTON & BIRD LLP
2025 · second_quarter · Q2
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding the Orphan Drug Act and rare disease diagnosis, treatment, and care. Legislation regarding kidney disease and in particular rare kidney disease. Legislation regarding newborn screening. H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Policies regarding copay accumulators and impact on rare disease patients. Support of reauthorization of priority review voucher program. H.R.1, One Big Beautiful Bill Act, provisions regarding orphan drugs.
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation impacting products approved under the Accelerated Approval pathway. H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Policies regarding copay accumulators and impact on rare disease patients. H.R.1, One Big Beautiful Bill Act, provisions regarding orphan drugs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · second_quarter · Q2
General health care issues related to Medicare coverage policies.
General health care issues related to Medicare coverage policies.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN MEDICAL REHABILITATION PROVIDERS ASSOCIATION via ALSTON & BIRD LLP
2025 · first_quarter · Q1
Medicare reimbursement issues.
Medicare reimbursement issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TIVITY HEALTH, INC. via ALSTON & BIRD LLP
2024 · fourth_quarter · Q4
Older Americans Act and Medicare and healthcare issues. Reimbursement for prescribed physical activity.
Older Americans Act and Medicare and healthcare issues.
ST. JUDE CHILDREN'S RESEARCH HOSPITAL via ALSTON & BIRD LLP
2024 · fourth_quarter · Q4
Issues related to Medicaid; Public Readiness and Emergency Preparedness Act (PREP). H.R.3433/S.2897, Give Kids a Chance Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE